Dong-A releases new form of peripheral vasodilator

Published: 2010-11-02 06:57:00

Updated: 2010-11-02 06:57:00

Dong-A Pharmaceutical Co. says it will supply new package of Opalmon (limaprost), peripheral vasodilator, from November 1, as its price was reduced by 20 percent. Limaprost, an alprostadil (prostaglandin E1) analogue, is a vasodilator that increases blood flow and inhibits platelet aggregation.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK